We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
8.00 | 0.57% | 1,408.00 | 1,403.00 | 1,414.00 | 1,426.00 | 1,365.00 | 1,400.00 | 660,233 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 952.03 | 1.91B |
Date | Subject | Author | Discuss |
---|---|---|---|
20/11/2023 07:58 | Should see some buying today. Share purchase programme starts. GLA | youngers | |
17/11/2023 16:58 | Personally I would rather see cash re-deployed in the business than simply propping up the share price short-term with share buybacks. Maybe more bolt-on acquisitions to further diversify revenues? I understand and appreciate management's confidence in cashflow and growth prospects, but the cash pile has taken quite a hit in the last two years (with a few payments still yet to be made). I would prefer cash conservation and balance sheet flexibility to buybacks. Even a dividend or two wouldn't go amiss! | redwing1 | |
17/11/2023 15:43 | Yes today's announcements are positive and have probably steadied the shareholder boat- its a view! However read between the lines and just quite possibly one can start to comprehend what has been happening! Also,there is a new biggish shareholder, Madison Partners LP . I say new as I cannot trace them as shareholders previously but do check, maybe that's me! If it is a new shareholder then we haven't quite seen the full story yet as the stock has come from somewhere. I suspect today's announcements tell some of the story but not quite all. Could it possibly be Scopia's revised shareholding agreement has already been acted upon? Whatever has been driving the recent share price weakness and the above maybe well wide of the mark!, today's statements on trading , prospects etc and the proposed major share buy back program have reassured me in quite a big way. Doesn't mean to say I am right! | gregmorg | |
17/11/2023 14:12 | Doesn’t get much more confident than this: “Given our confidence in delivering on the medium-term profitable growth profile we outlined at our capital markets day last December, the Board of Directors and management team believe that the Company's shares represent an attractive investment opportunity," said Mark Crossley, Chief Executive Officer. "Our expected strong cash flow over this period provides us the ability to reinvest in our business, progress our pipeline, and to take this action to deliver direct shareholder returns." | youngers | |
17/11/2023 12:34 | That’s great news. I think mgmt probably a bit surprised by the reaction to removing all the legal hangover and then the results announcement. Expecting a big push at q4 results to set out a compelling vision for the future with significant profitability to drive a re rating in this stock | youngers | |
17/11/2023 12:22 | Good news. market is however so dysfunctional that there is no buying | dealy | |
17/11/2023 12:09 | RNS...... share buy back announcement!! | pngasef | |
15/11/2023 14:03 | volume is very low | dealy | |
15/11/2023 11:14 | Biggest faller on the FTSE350 today. Quite an achievement... | liam1om | |
14/11/2023 19:58 | Yeah. I got fomo after missing out on the 100 point or so jump. I'll be in the red by Friday I think. | casholaa | |
14/11/2023 15:50 | Buyers are back now though, happy days. | pngasef | |
14/11/2023 08:05 | This sell off has taken place without any announced reduction in holdings by large holders. | dealy | |
13/11/2023 08:58 | I make that 7 down days in a row. Worst run its had in a long time and again in the top three biggest losers on the FTSE350. Crazy. | liam1om | |
12/11/2023 12:01 | Its noticeable that second line stocks,especially those that don't pay a dividend,are getting particularly badly hit in these markets.It could be a function of the 'risk free' interest now readily available elsewhere but combined with a general risk aversion,a lot of stocks are vulnerable.Anyway,In | steeplejack | |
10/11/2023 17:12 | Over the last 3 years or so, my stops have kicked in at least 3 times. I've learnt it gives way a lot when it moves in either direction. | casholaa | |
10/11/2023 16:43 | Well I listened quite intensely to the company and to the Q and A which can highlight any added theme but didn’t get any unknowns popping up . Maybe the bears in this market are the only active participants! | gregmorg | |
10/11/2023 16:43 | Well I listened quite intensely to the company and to the Q and A which can highlight any added theme but didn’t get any unknowns popping up . Maybe the bears in this market are the only active participants! | gregmorg | |
10/11/2023 16:16 | Steeplejack - I don't think the post from ShearClass does sum things up very well. They are wide of the mark with suboxone because the entry of a 4th generic competitor has been pushed back later in the year more than once and hence suboxone sales have held up ok. The generic competition is already well known and is becoming less relevant each quarter as Sublocade grows. Sublocade and Perseris will account for at least $645m out of a total c$1050m sales this year. Perseris guidance is a small negative but not that significant and I suspect it is too early to talk about the Opvee launch. The impact of the recent legal settlement on the balance sheet should be well known and still leaves Indivior with net cash to pay the remaining DOJ instalments. Something has obviously spooked the institutions from the conference call but I can't fathom what. Looks oversold to me. | redwing1 | |
10/11/2023 16:00 | Am right in thinking that the total liabilities and provisions at the moment equate to $880 million. $440m provisions (DP class settlement etc) and $440m liabilities (DOJ. etc). Cash $610 m (plus $160m in investments). Thanks. | elsa7878 | |
10/11/2023 13:54 | Listened to the webcast and everything seemed Okay but nothing more than that-- didn't have a buzz, one was or the other, at the end of it. I admit I did think it could drift for a while as there was no added aspect that one could focus on. Not the first time with Indivior's 3rd quarter results that I recall. Perseris sales, from a low overall group base were fine that I can see - very much in line but the annual guidance was adjusted to a lower end of earlier projected range because of some new competing product launch but appeared no big deal. Longer term hopes still very positive. Yet product potential not big in the context of the whole. Sublocade growth going along well. Added costs and provisions were to be expected so a 3rd quarter loss was inevitable.My take is these overall markets take no prisoners and an element of throwing in the towel and capitulation is upon us. Historically that's often an interesting time. Not enjoying this after the years and years of tribulations but we will see. | gregmorg | |
10/11/2023 11:26 | I've taken this from LSE.Post by ShearClass.It sums things up succinctly i think. I suspect it's due to a multitude of factors; - Sublingual revenues seeing a rapid decline YoY, offsetting Sublocade increases - Below expectations performance of Perseris - No detail on Opvee launch / revenue expectations - Market digesting the balance sheet impact of the massive final settlement & not liking what it sees Ultimately, operating profit is running at ~$225m PA, what we don't know is how much of that is related to sublingual. If revenues continue to decline there as expected, then without a major Opvee launch the top line growth will stall. Essentially things are in the balance, however sentiment has turned negative due to the above factors. Downtrend support sits at ~£11.80 as far as I se | steeplejack | |
10/11/2023 11:11 | Not a holder but must be a broker downgrade. Selling started as the conference call started yesterday so must be something that was said. | elsa7878 | |
10/11/2023 08:19 | Second biggest faller on the FTSE350 today. Amazing. | liam1om |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions